Current News

Contact | Print version | PDF version | Send article | RSS feed

Codexis Opens Singapore Laboratory

26 Oct 2007 - Codexis, Inc. announced the opening of Codexis Laboratories Singapore Pte. Ltd. (CLS). CLS is the company's first research facility in Asia, and is an expansion of the company's research and development operations in the U.S. and Europe. CLS will support the company's pharmaceuticals business in both the innovator and generics markets.
 
"Our expansion to Singapore is a significant part of our global development strategy," Alan Shaw, Ph.D., Codexis President and Chief Executive Officer said. "Singapore offers us access to a highly skilled workforce, proximity to our growing customer base in Asia, and a productive business environment as our company grows. Codexis Laboratories Singapore will play an important role in the development of new products serving our pharmaceuticals markets worldwide."
 
The 20,000-square foot research and development center is in the Galen, in the Science Park III area of Singapore. When fully staffed, it is expected to house up to 70 R&D and operations personnel.